Orthofix Medical Inc.
OFIX
$11.99
$0.121.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.97% | 4.59% | 2.27% | 2.67% | 7.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.97% | 4.59% | 2.27% | 2.67% | 7.61% |
| Cost of Revenue | 4.46% | -7.22% | -0.44% | 17.37% | 12.37% |
| Gross Profit | 0.93% | 9.97% | 3.55% | -4.42% | 5.72% |
| SG&A Expenses | 0.20% | 13.84% | 1.70% | 0.98% | 3.85% |
| Depreciation & Amortization | -29.46% | -31.44% | -10.33% | -53.73% | 0.49% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.71% | 4.49% | -0.26% | 3.97% | 5.65% |
| Operating Income | 67.67% | -3.27% | 23.22% | -11.99% | 27.25% |
| Income Before Tax | 92.62% | 16.42% | 56.05% | -48.24% | -34.75% |
| Income Tax Expenses | 105.32% | -29.03% | -113.10% | 12.93% | -551.20% |
| Earnings from Continuing Operations | 92.38% | 16.77% | 57.90% | -47.40% | -31.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 92.38% | 16.77% | 57.90% | -47.40% | -31.44% |
| EBIT | 67.67% | -3.27% | 23.22% | -11.99% | 27.25% |
| EBITDA | -34.28% | -990.57% | 119.55% | 110.70% | 266.92% |
| EPS Basic | 92.62% | 19.45% | 59.47% | -41.96% | -26.68% |
| Normalized Basic EPS | 79.97% | 11.07% | 50.76% | 0.81% | -81.02% |
| EPS Diluted | 92.40% | 19.45% | 59.09% | -41.96% | -26.68% |
| Normalized Diluted EPS | 79.97% | 11.07% | 50.76% | 0.81% | -81.02% |
| Average Basic Shares Outstanding | 3.36% | 3.32% | 3.90% | 3.83% | 3.75% |
| Average Diluted Shares Outstanding | 3.36% | 3.32% | 3.90% | 3.83% | 3.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |